Back
Gold Fields Vs. CRISPR Therapeutics AG Industry Stock Comparison
Buy
72
GFI
Gold Fields
Last Price:
$24.00
Seasonality Move:
0.75%
Sell
27
CRSP
CRISPR Therapeutics AG
Last Price:
$37.78
Seasonality Move:
21.79%
Buy
72
Gold Fields (GFI)
is a Buy
Is Gold Fields a Buy, Sell or Hold?
-
The current Gold Fields [GFI] share price is $23.99. The Score for GFI is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
-
GFI is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
27
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
-
The current CRISPR Therapeutics AG [CRSP] share price is $37.77. The Score for CRSP is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
CRSP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GFI Stock Price Chart
What is Gold Fields's stock price today?
-
The Gold Fields share price today is $23.99Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GFI is experiencing slight selling pressure.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $37.77Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRSP is experiencing slight buying pressure.
GFI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.06 | Buy |
| Relative Strength Index (14 RSI): | 61.39 | Buy |
| Chaikin Money Flow: | -2261036 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.51 - 23.37) | Buy |
| Bollinger Bands (100): | (14.4 - 20.88) | Buy |
CRSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.36 | Buy |
| Relative Strength Index (14 RSI): | 49.46 | Sell |
| Chaikin Money Flow: | 99115 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.98 - 41.22) | Buy |
| Bollinger Bands (100): | (37.58 - 47.38) | Sell |
GFI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.22 | Buy |
| 20-day SMA: | 22.13 | Buy |
| 50-day SMA: | 20.51 | Buy |
| 200-day SMA: | 16.65 | Buy |
| 8-day EMA: | 23.44 | Buy |
| 20-day EMA: | 22.36 | Buy |
| 50-day EMA: | 20.58 | Buy |
| 200-day EMA: | 17.35 | Buy |
CRSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.63 | Buy |
| 20-day SMA: | 36.55 | Buy |
| 50-day SMA: | 40.9 | Sell |
| 200-day SMA: | 46.21 | Sell |
| 8-day EMA: | 36.89 | Buy |
| 20-day EMA: | 32.04 | Buy |
| 50-day EMA: | 20.78 | Buy |
| 200-day EMA: | 6.95 | Buy |
Gold Fields Earnings Growth & GFI Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.16 per share, an increase next quarter of $0.02 per share, an increase this year of $0.96 per share, and an increase next year of $0.18 per share.
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.18 per share, an increase next quarter of $0.02 per share, an increase this year of $0.20 per share, and an increase next year of $0.91 per share.
Gold Fields Technical Analysis
| Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
CRISPR Therapeutics AG Technical Analysis
| Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||